First came the denials, then - finally - the admission that, yes indeed, some of GlaxoSmithKline's senior Chinese executives broke the law in a $484.8 million cash and sexual favors scandal. Britain's Guardian newspaper reported on July 22 that the mega-drugmaker's...


Read More...